This was in line with the findings from several recent studies reporting that biomarkers such as high HBV DNA load or HBeAg seroconversion predict the increased risk or mortality of various liver diseases only in patients with normal serum ALT levels [10], [22]–[24], which further indicated the complexity of ALT as an HCC risk factor. Here, GPT is linked to hepatocellular carcinoma.